[Skip to Content]
[Skip to Content Landing]
Citations 0
Capitol Health Call
June 9, 2010

Heparin Contamination

JAMA. 2010;303(22):2241. doi:10.1001/jama.2010.721

Leading Republicans on the House Energy and Commerce Committee are asking the Food and Drug Administration (FDA) what the agency is doing to pursue credible leads in investigating Chinese firms implicated in supplying imported contaminated heparin that killed scores of people and sickened hundreds starting in 2008.

In a letter sent on April 30, ranking minority member Rep Joe Barton (R, Tex) and ranking minority member of the Oversight and Investigations Subcommittee, Michael Burgess, MD, (R, Tex), asked FDA Commissioner Margaret A. Hamburg, MD, to answer questions on the agency's handling of the heparin contamination investigation (http://republicans.energycommerce.house.gov/Media/file/News/043010_Letter_to_FDA_Heparin.pdf).

First Page Preview View Large
First page PDF preview
First page PDF preview